| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 10/09/2007 | US7279304 Methods for preparation of macrocyclic molecules and macrocyclic molecules prepared thereby |
| 10/09/2007 | US7279172 Treatment of autoimmune conditions with copolymer 1 and related copolymers |
| 10/09/2007 | US7279170 Recombinant polypeptides, which can be used as purified antigens for the detection and control of tuberculosis |
| 10/09/2007 | CA2396174C Aerothricin analogs, their preparation and use |
| 10/09/2007 | CA2272881C Assay method for peptide specific t-cells |
| 10/09/2007 | CA2156416C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 10/04/2007 | WO2007111969A2 C-reactive protein apheresis |
| 10/04/2007 | WO2007110772A1 Immunomodulating oligopeptides |
| 10/04/2007 | WO2007110765A2 Processes for the preparation of octreotide |
| 10/04/2007 | WO2007110632A1 Bacterial vaccine |
| 10/04/2007 | WO2007109908A1 Therapeutic yb-1 phosphorylation decoys |
| 10/04/2007 | WO2007079558B1 Proline-rich peptides, pharmaceutical composition, use of one or more peptides and method of treatment |
| 10/04/2007 | WO2007038172A3 Guanidinium carriers |
| 10/04/2007 | WO2005046575A3 Amino acid prodrugs |
| 10/04/2007 | WO2004071457A3 Improved heat shock protein-based vaccines and immunotherapies |
| 10/04/2007 | US20070232549 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 10/04/2007 | US20070232546 Linear Natriuretic Peptide Constructs |
| 10/04/2007 | US20070232537 Intranasal pyy formulations with improved transmucosal pharmacokinetics |
| 10/04/2007 | US20070232522 For modulating immune activity, hepatitis infections, the extent of nephritis, and the growth of a cancer |
| 10/04/2007 | US20070231830 Using competitive binding assays to identify peptide modulators for signal transduction |
| 10/04/2007 | US20070231404 Preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium |
| 10/04/2007 | US20070231376 Methods and compositions for modulating axonal outgrowth of central nervous system neurons |
| 10/04/2007 | US20070231284 Melanocyte Stimulating Hormone; new peptides and peptidic conjugates containing at least 6 amino acids and including the sequence DPhe-Arg have a substantial activating effect on melanogenesis in the melanocytes of the hair bulb |
| 10/03/2007 | EP1840133A1 New immunomodulating oligopeptides |
| 10/03/2007 | EP1840082A1 Nanographite structure/metal nanoparticle composite |
| 10/03/2007 | EP1839673A2 Prevention and treatment of hypergastrinemia |
| 10/03/2007 | EP1838725A1 C5a receptor antagonists |
| 10/03/2007 | EP1704160A4 Methods and compositions for identifying rna-binding proteins |
| 10/03/2007 | EP1355940B1 Urotensin-ii agonists and antagonists |
| 10/03/2007 | CN101048170A Analgesic peptide like compounds stemed from rattlesnake crotalus durissus terrificus snake wenom, their application, compositions, preparation and purification method |
| 10/03/2007 | CN101045747A Blood pressure depressed peptide from royal jelly |
| 10/03/2007 | CN101045744A Anti-titanium oxide from collagen and its use |
| 10/03/2007 | CN100340573C Heterocarpine, human GHRH-binding protein |
| 10/03/2007 | CN100340572C Novel LHRH antagonist |
| 10/02/2007 | US7276482 Peptide and peptide mimetic derivatives with integrin-inhibitors properties II |
| 10/02/2007 | US7276474 Methods of making and using surfactant polymers |
| 10/02/2007 | US7276375 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate |
| 10/02/2007 | US7276341 Methods and reagents for diagnosis of autoantibodies |
| 10/02/2007 | US7276248 Conjugate having a cleavable linkage for use in a liposome |
| 10/02/2007 | CA2168583C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 09/27/2007 | WO2007109299A2 Peptide |
| 09/27/2007 | WO2007108749A1 Chimeric constructs between cancer-homing peptides and cell-penetrating peptides coupled to anticancer drugs and/or diagnostic agent/agents |
| 09/27/2007 | WO2007107654A1 Cyclopeptide with anti-cancer activity derived from collagen type iv |
| 09/27/2007 | WO2007107587A2 Cholesterol lowering protein hydrolysates |
| 09/27/2007 | WO2007106951A1 Antimicrobial protein |
| 09/27/2007 | WO2007057872A3 Casein-derived antimicrobial peptides and lactobacillus strains that produce them |
| 09/27/2007 | WO2007050531A3 Diagnostic application of mail |
| 09/27/2007 | WO2006047315A3 Targeted delivery of biological factors using self-assembling peptide nanofibers |
| 09/27/2007 | US20070225226 C-reactive protein apheresis |
| 09/27/2007 | US20070225222 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 09/27/2007 | US20070225221 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 09/27/2007 | US20070225215 Modulation of Cartilage Homeostasis By Active Domains of Cell Binding Extracellular Matrix Molecules |
| 09/27/2007 | CA2641064A1 Antimicrobial protein |
| 09/26/2007 | EP1837344A1 Tumor necrosis factor receptor-derived peptide analogues |
| 09/26/2007 | EP1836217A2 Anti-tumoral immunogenic peptides and vaccine thereof |
| 09/26/2007 | EP1836216A1 Binding partners of antibodies specific for dendritic cell antigens |
| 09/26/2007 | EP1835926A2 Plasmin-inhibitory therapies |
| 09/26/2007 | EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c |
| 09/26/2007 | EP1272510B1 Pharmacologically active antiviral peptides and methods of their use |
| 09/26/2007 | EP1047708B1 Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center |
| 09/26/2007 | EP1035865B1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/26/2007 | EP0787191B1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 09/26/2007 | CN101044160A Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor |
| 09/26/2007 | CN101041689A Derivative of cyclosporins C and D and pharmaceutical composition thereof |
| 09/26/2007 | CN101041688A Solid-phase synthesizing method for synthesizing hydroxyl radical polypeptide storeroom by using volatile aminoalkyl radical silica gel |
| 09/26/2007 | CN101041687A PGE2 differential combined phage lambda ring seven peptide and sifting method and usage of synthesized peptide |
| 09/26/2007 | CN100339390C Coronavirus specific T-cellantigen determinate cluster |
| 09/26/2007 | CN100339388C New assays for preimplantation factor and preimplantation factor peptides |
| 09/25/2007 | US7273929 B1k chain of laminin and methods of use |
| 09/25/2007 | US7273920 Controlling protein levels in eucaryotic organisms |
| 09/25/2007 | US7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/25/2007 | US7273846 Selective melanin-concentrating hormone type-1 receptor agonists |
| 09/25/2007 | US7273708 Assays for preimplantation factor and preimplantation factor peptides |
| 09/25/2007 | US7273614 Inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells. |
| 09/25/2007 | CA2256516C Peptides |
| 09/25/2007 | CA2112701C Proteins s polypeptides and uses thereof |
| 09/20/2007 | WO2007105565A1 Peptide for inhibition of influenza infection, inhibitor of influenza infection, liposome, and prophylactic/therapeutic agent for influenza |
| 09/20/2007 | WO2007105224A1 Combination of cytokine and cytokine receptor for altering immune system functioning |
| 09/20/2007 | WO2007104196A1 Lhrh antagonist possessing low histamine releasing effect |
| 09/20/2007 | WO2007090630A3 Peptide aptamer for neutralizing the binding of platelet antigene specific antibodies and diagnostic and therapeutic applications containing the same |
| 09/20/2007 | WO2007041568A3 Compositions and method for regulating ubiquitin-specific processing proteases |
| 09/20/2007 | WO2007039728A3 AVß6 PEPTIDE LIGANDS AND THEIR USES |
| 09/20/2007 | WO2007019860A3 Gdnf derived peptides |
| 09/20/2007 | US20070219354 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 09/20/2007 | US20070219347 Meningitidis B serogroup; amino acid sequence encoded by nucleotides 564043 to 565882 of sequence 1; monoclonal antibodies; vaccine antigens |
| 09/20/2007 | US20070219139 Immune-modulating peptide |
| 09/20/2007 | US20070219138 Compositions capable of reducing elevated blood urea concentration |
| 09/20/2007 | US20070219137 Novel Potassium Channel Modulator Peptide |
| 09/20/2007 | US20070219136 Methods and compositions for treating inflammatory disorders |
| 09/20/2007 | US20070219134 Lymphatic zip codes in tumors and pre-malignant lesions |
| 09/20/2007 | US20070218504 Human leptin-derived polypeptides and uses thereof |
| 09/20/2007 | US20070218080 Peptide antigen of human papillomavirus type 16 and application thereof |
| 09/20/2007 | US20070218051 Epitope peptides immunogenic against Streptococcus pneumoniae |
| 09/20/2007 | CA2649261A1 Influenza infection-inhibiting peptide, influenza virus-infection inhibitor, liposome and influenza preventive/therapeutic agent |
| 09/20/2007 | CA2646931A1 Combination of cytokine and cytokine receptor for altering immune system functioning |
| 09/19/2007 | EP1834961A2 Design of chemokine analogs for the treatment of human diseases |
| 09/19/2007 | EP1833844A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 09/19/2007 | EP1572066A4 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 09/19/2007 | CN101039953A Therapeutic and diagnostic agents |
| 09/19/2007 | CN101037473A R. grahami rnmunoregulating polypeptide, gene and variant and its application in medicine production |